Challenges in oral administration of metronidazole dissolved in drinking water to rhesus monkeys (Macaca mulatta)

Linda Labberton1, Jaco Bakker, Rianne Klomp

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Lab Animal
|May 22, 2013
PubMed

Insights

Treating intestinal protozoan infections in rhesus macaques with metronidazole in drinking water proved impractical. Drug administration via water led to reduced fluid intake and variable dosing, highlighting challenges in nonhuman primate treatment.

Area of Science:

  • Veterinary Medicine
  • Primatology
  • Infectious Diseases

Background:

  • Intestinal protozoan infections (Entamoeba spp., Giardia spp.) are common in research rhesus macaques.
  • These infections impact macaque health and pose zoonotic risks to humans.
  • Standardized treatment protocols for these infections in nonhuman primates are lacking.

Purpose of the Study:

  • To evaluate the efficacy of oral metronidazole administration in drinking water for treating intestinal protozoan infections in rhesus macaques.
  • To assess the feasibility of using flavored syrup to improve palatability and intake.

Main Methods:

  • Rhesus macaques were monitored for daily fluid intake.
  • Groups received plain water, metronidazole in water, or metronidazole with flavored syrup.
  • Fluid intake was compared across groups.

Main Results:

  • Metronidazole, with or without flavored syrup, significantly decreased macaque fluid intake.
  • Variability in water and metronidazole consumption was observed among individuals.
  • This method did not ensure consistent drug delivery.

Conclusions:

  • Oral administration of metronidazole in drinking water is not a practical or reliable method for treating intestinal protozoan infections in rhesus macaques.
  • Challenges in consistent drug dosing and reduced fluid intake limit its clinical utility.
  • Further research into effective and practical drug delivery methods is warranted for nonhuman primates.